Identification of type-specific anticancer histone deacetylase inhibitors: road to success Nighat NoureenHamid RashidSaima Kalsoom Mini Review 17 April 2010 Pages: 625 - 633
Antitumor activity and pharmacokinetics of oral gimatecan on pediatric cancer xenografts Massimo ZucchettiDaniela MecoRiccardo Riccardi Original Article 20 December 2009 Pages: 635 - 641
Concurrent chemoradiation followed by adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma in Korea Kyong Hwa ParkJeong Sun KimNam Joon Lee Original Article 23 December 2009 Pages: 643 - 651
The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia T. Adam de BeaumaisT. DervieuxE. Jacqz-Aigrain Original Article 23 December 2009 Pages: 653 - 658
Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy Seung Tae KimJeeyun LeeYoung Suk Park Original Article 24 December 2009 Pages: 659 - 667
Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation study Francisco RobertAlan SandlerAnne M. Traynor Original Article Open access 31 December 2009 Pages: 669 - 680
Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity Sampa GhoshalIndranil RaoMeir Wetzler Original Article 25 December 2009 Pages: 681 - 689
Impact of functional ABCG2 polymorphisms on the adverse effects of gefitinib in Japanese patients with non–small-cell lung cancer Keiichi AkasakaTakayuki KaburagiYasuo Imai Original Article 25 December 2009 Pages: 691 - 698
Pharmacokinetics of sunitinib malate in subjects with hepatic impairment Carlo L. BelloMay GarrettMelvin Toh Original Article 05 January 2010 Pages: 699 - 707
Corchorusin-D, a saikosaponin-like compound isolated from Corchorus acutangulus Lam., targets mitochondrial apoptotic pathways in leukemic cell lines (HL-60 and U937) Sumana MallickPapiya GhoshJoseph R. Vedasiromoni Original Article 24 December 2009 Pages: 709 - 719
Phase II study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer Yasushi SatoTetsuji TakayamaJunji Kato Original Article 30 December 2009 Pages: 721 - 728
Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck Mamoru TsukudaJunichi IshitoyaMasanori Komatsu Original Article 24 December 2009 Pages: 729 - 736
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors Elizabeth FoxJohn M. MarisFrank M. Balis Original Article 01 January 2010 Pages: 737 - 743
Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice Yasumichi YagiSachio FushidaTetsuo Ohta Original Article 24 December 2009 Pages: 745 - 753
Inhibition of experimental colorectal cancer and reduction in renal and gastrointestinal toxicities by copper–indomethacin in rats Antonio M. BoninJaime A. YáñezNeal M. Davies Original Article 25 December 2009 Pages: 755 - 764
PXR-mediated induction of P-glycoprotein by anticancer drugs in a human colon adenocarcinoma-derived cell line Stefan HarmsenI. MeijermanJ. H. M. Schellens Original Article Open access 30 December 2009 Pages: 765 - 771
Intravenous paclitaxel against metastasis of human gastric tumors of diffuse type Tsung-Fan TuanMeng-Li TsaiChiung-Tong Chen Original Article 01 January 2010 Pages: 773 - 783
Semi-mechanistic population pharmacokinetic/pharmacodynamic model for neutropenia following therapy with the Plk-1 inhibitor BI 2536 and its application in clinical development Elena SotoAlexander StaabIñaki F. Trocóniz Original Article 09 January 2010 Pages: 785 - 795
Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design Yong Wha MoonSun Young RhaHyun Cheol Chung Original Article 11 March 2010 Pages: 797 - 805
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials Tomasz ZarembaHuw ThomasNicola J. Curtin Short Communication 21 May 2010 Pages: 807 - 812
Pharmacokinetic analysis of carboplatin in patients with cancer who are undergoing hemodialysis Tomoyo OguriTomoya ShimokataYoshinori Hasegawa Short Communication 19 June 2010 Pages: 813 - 817
